News Daily News Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis Michael O'Riordan January 26, 2016
News Features PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data Michael O'Riordan January 25, 2016
News Industry News Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol January 21, 2016
News Daily News Refreshed Dietary Guidelines Shift Focus to Healthy Eating Patterns Todd Neale January 18, 2016
News Daily News USPSTF Issues Preliminary Recommendations on Statin Use in Primary Prevention Michael O'Riordan January 12, 2016
News Daily News Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond December 23, 2015
News Daily News For Interventional Trials, Optimal Medical Management May Entail as Much Training as New Techniques Todd Neale December 20, 2015
News Daily News ¿Estatinas para el Manejo de la Calcificación Aórtica? Un Estudio de Imágenes Debate sobre el Papel de las LBD en la Enfermedad de la Válvula Aórtica Shelley Wood December 16, 2015
News Daily News Statins for Aortic Calcification? Imaging Study Reopens Debate Over LDL’s Role in Aortic Valve Disease Shelley Wood December 16, 2015
News Daily News Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee Michael O'Riordan December 15, 2015
News Daily News ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention Michael O'Riordan December 13, 2015
News Daily News NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication Michael O'Riordan December 08, 2015
News Daily News Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk Michael O'Riordan December 02, 2015
News Daily News Las Noticias Negativas sobre las Estatinas se asociaron a su Interrupción y a Más Riesgo CV Michael O'Riordan December 02, 2015
News Industry News Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled November 23, 2015
News Conference News AHA 2015 Degree of LDL Cholesterol-Lowering on High-Intensity Rosuvastatin Determines Clinical Impact Todd Neale November 12, 2015